Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder

NCT00617396 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Functional Bowel Disorders

Interventions

DRUG: Quetiapine (50 mg/day-100mg/day)

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]